IASLC's Guide to COVID-19 and Lung Cancer

Access to CME

The IASLC is collecting member and patient experiences with COVID-19 as a way to pool knowledge and connect our members during this public health crisis. These stories, information from the Journal of Thoracic Oncology (JTO), and official statements from the IASLC will be published on this page. In addition, this page will feature links to important resources such as journal articles and social media groups relevant to the care of patients with lung cancer.

If you would like to share a video or written statement about your personal interactions, concerns, guidance and hopes, please send your submission via email to [email protected]. Instructions about how to transfer video files will be supplied as requested.

IASLC Exclusive

Drs Cardona, Pino, and Arrieta

Economics of Locally Advanced Lung Cancer Before and During COVID-19 Pandemic: A Perspective for Developing Countries

IASLC Studying Impact of COVID-19 on International Lung Cancer Clinical Trial Enrollment, Mitigation Strategies

Paul Bunn, MD and Tetsuya Mitsudomi, MD

COVID-19 resulted in significant changes to enrollment, conduct, and funding of clinical trials on an international scale. 

COVID-19 and Lung Cancer: A Call for Immediate Action

David R. Baldwin

The October UKLCC report makes a slightly enigmatic statement that at least one-third of patients with lung cancer in the UK will have does over the 6-month period of the then-duration of the pandemic. 

Research's Race to Stop a Pandemic

Data Retractions

Data about COVID-19 and Sars-CoV-2 is coming out fast and furious, which has both pros and cons. 

SBRT Versus Surgery in the COVID-19 Era: WHat has Changed and What Hasn't?

Suresh Senan, MRCP, FRCR, PhD

Surgery is considered the preferred treatment in patients with lung cancer who are fit to undergo the procedure. Stereotactic radiotherapy (SBRT) is guideline recommended for patients who are unfit for surgery or who decline to undergo the procedure. 

CT Findings of COVID-19 Pneumonia and Mimicking Diseases in Patients with Lung Cancer

Figure-1-CT-COVID_Yoon v2

The COVID-19 pandemic has caused more than 43.2 million cumulative cases and 1.16 million deaths, as of late October 2020. Approximately 1% of patients with COVID-19 have malignancy,1 and lung cancer accounts for a considerable portion of these malignancies. 

Building and Maintaining a Patient-Physician Relationship in the COVID-19 Era

Ramirez_Robert

As oncologists, we recognize that the patient–physician relationship is of utmost importance in establishing the patient’s trust in the physician and in the physician’s ability to learn more about the patient’s needs and perform accurate assessments for treatment planning. 

The Impact of COVID-19 on Clinical Trials: An FDA Perspective

Singh_Harpreet_1602x1005

Harpreet Singh, MD, is director of Division of Oncology 2 at the U.S. Food and Drug Administration (FDA). In the following interview, she discusses the FDA’s response to the COVID-19 pandemic in how clinical trials are conducted, as well as the implications of these changes and what can be expected going forward.

TERAVOLT Progress

Garassino_mask_1602x1005

In her Virtual Presidential Symposium presentation, Dr. Garassino, of the Fondazione IRCCS Istituto Nazionale de Tumori, Milan, reviews COVID-19-related morbidity across cancer types and within thoracic cancers specifically, and she discusses the next steps for TERAVOLT data, as well as for clinical trials in the COVID-19 era. 

Lung Cancer Surgery in the COVID-19 Era: What has Changed

Corona-Cruz_Jose_1602x1005

For many patients with lung cancer, local treatments such as surgery or stereotactic body radiation therapy (SBRT) are the only opportunity for cure, and thoracic oncology teams may have the difficult decision of weighing the utility of these interventions against the risk of inadvertent COVID-19 exposure for patients and medical staff. 

Member Stories

Member Story: Dr. Noemi Reguart

Member Story: Dr. Noemi Reguart

Dr. Noemi Reguart is a medical oncologist at the Hospital Clínic in Barcelona, Spain.
In Spain, these past few weeks have been difficult—especially for health care personnel. The coronavirus took off fast, and we had very little time to prepare.

Member Story: Suraj Samtani Bassarmal

Member Story: Suraj Samtani Bassarmal

Dr. Suraj Samtani is a medical oncologist living and working in Santiago, Chile.
 

Member Story: Dr. Shengxiang Ren

Member Story: Dr. Shengxiang Ren

Dr. Shengxiang Ren is an associate professor at Shanghai Pulmonary Hospital, Tongji University and Vice Director at Shanghai Pulmonary Hospital. 

Member Story: Dr. Amy Moore

Member Story: Dr. Amy Moore

Dr. Amy Moore is the Director of Science and Research for the GO2 Foundation for Lung Cancer and based in the San Francisco Bay area, shares her thoughts on the current COVID-19 pandemic and what it means for the lung cancer community.
 

Member Stories: Dr. Ross Soo

Member Stories: Dr. Ross Soo

In Singapore, a first confirmed case of COVID-19 was reported in late January and, since then, government measures to contain the first wave of infections have resulted to be effective. 

Member Stories: Dr. Brendon Stiles

Member Stories: Dr. Brendon Stiles

New York City has been hit hard by the pandemic. A lot of what we see on the news in the U.S. has to do with equipment shortages, but Dr. Brendon Stiles sends us some optimistic news from the heart of the city.

Member Stories: Dr. Anand Sachithanandan

Member Stories: Dr. Anand Sachithanandan

Dr. Anand Sachithanandan is a consultant cardiothoracic surgeon in private practice in greater Kuala Lumpur. He is co-founder and president of Lung Cancer Network Malaysia, an NGO that aims to improve outcomes from lung cancer through awareness, advocacy and education.

Member Stories: Dr. Narjust Duma

Member Stories: Dr. Narjust Duma

From patients who are worried about being passed over for life-saving treatment to physicians who are missing the valuable coping measures that tangible interactions provide, Dr. Duma describes the weight the pandemic has placed on her and those for whom she cares.

Member Stories: Janet Freeman-Daily

Member Stories: Janet Freeman-Daily

Janet is a retired aerospace systems engineer, freelance writer, and metastatic lung cancer patient/activist. Diagnosed in 2011, her focus is now on translating the experience and science of lung cancer for others. 

IASLC Webinars

Supportive Care of Lung Cancer Patients during COVID-19

meeting/webinar default banner 01

Nurses and Allied Health Professionals from the United States, Australia and United Kingdom will discuss real world supportive care challenges faced by lung cancer patients during the time of pandemic.

Managing Clinical and Translational Research During COVID

meeting/webinar default banner 01

This webinar utilizes a team approach to explore challenges and provide best practices for conducting clinical and translational research during the COVID pandemic. 

Managing Lung Cancer in the Time of COVID-19

2020-August-25-COVID-19-Global-Webinar-Speakers-1200x628

This Medscape Education and IASLC Exclusive Webinar: Immunotherapy and the COVID-19 Pandemic: Addressing Clinical Case Challenges in Lung Cancer discusses key issues regarding the use of immunotherapy today.

Treatment of Lung Cancer: 2020 ASCO Highlights

webinar_07312020

This one-hour live session synthesized lung cancer research presented at the May 29-31, 2020 virtual meeting of the American Society of Clinical Oncology (ASCO). 

Impact of COVID-19 on the Diagnostic Workup of Lung Cancer

Impact of COVID-19 on the Diagnostic Workup of Lung Cancer

The COVID-19 pandemic has created numerous challenges with the management of lung cancer, not the least of which is the initial diagnosis. 

Systemic Therapy for Advanced Stage Lung Cancer During the COVID-19 Pandemic

Systemic Therapy for Advanced Stage Lung Cancer During the COVID-19 Pandemic

IASLC faculty members from Europe, Asia and North America will discuss systemic therapies including chemotherapy, immunotherapy, and targeted therapy for advanced-stage lung cancer during COVID-19

Impact of COVID-19 on Treatment of Lung Cancer Patients with Local or Locoregional Disease

Impact of COVID-19 on Treatment of Lung Cancer Patients with Local or Locoregional Disease

This webinar, "Impact of COVID-19 on Treatment of Lung Cancer Patients with Local or Locoregional Disease," will be presented by IASLC surgical and radiation...

Practical Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

Practical Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

This webinar will give a summary of recently published ESTRO & ASTRO practice guidelines about radiotherapy for lung cancer in the COVID-19 pandemic, whether radiotherapy...

Lung Cancer Considered Episodes

Developing the Moderna COVID-19 Vaccine

Image of lung cancer considered hosts and guests

This episode discusses the development of the Moderna COVID-19 vaccine what lung cancer patients, doctors, and advocates should know with dr. Tal Zaks the chief medical officer at Moderna, and Dr. Amy Moore. 

Tumor Mutational Burden and COVID19 – A Pathologist’s Perspective

Marty Edelman, MD, Lynette Sholl, MD, and John W. Longshore, PhD, FACMG

This episode focuses on a recent publication in IASLC's Journal of Thoracic Oncology that features new guidelines on Tumor Mutational Burden as well as the effects of COVID-19

COVID-19 Impact on Conferences and Social Media with Dr. Tatiana Prowell from the FDA

Tatiana Prowell, MD and Howard (Jack) West, MD

This episode focuses on the virtual format of the ASCO Annual meeting, implications for COVID-19 for how scientific and educational conferences will be structured, and the power of social media during a pandemic

IASLC Radiation Oncology and COVID-19 Webinar Recap

Corinne Faivre-Finn, MD, PhD, Walter J. Curran, MD, FACR, FASCO, Howard (Jack) West, MD

This episode focuses on radiation oncology, lung cancer, and COVID-19.

What Patients Need to Know About Lung Cancer Research in the Era of COVID-19

Default podcast image

This episode features patient advocates and lung cancer researchers on what patients need to know about lung cancer research in the era of COVID-19. 

Around The World: COVID-19 and Lung Cancer Tips and Experiences

Default podcast image

This episode focuses on a discussion between lung cancer experts from the U.S. and Europe discussing COVID-19 with regard to lung cancer patients with experiences, results and actions from different parts of the world.

COVID-19 Guidelines for Patients with Lung Cancer with Dr. Erin Bange

Default podcast image

This episode focuses on a collection of journal articles and guidelines about COVID-19 in patients with lung cancer. 

COVID-19 JTO Report with Dr. Shu-Yuan Xiao

Default podcast image

This episode discusses a COVID-19 report that was recently published in the Journal of Thoracic Oncology. The study covers the pathology of two COVID-19 positive patients from Wuhan who were originally treated for lung cancer.

COVID-19 Facts and Impacts for the Lung Cancer Community

Default podcast image

This episode discusses the impact of the COVID-19 epidemic on lung cancer patients and healthcare providers.

JTO and JTO CRR Articles

JTO cover 1

Journal of Thoracic Oncology COVID-19 Collection

Please find the most recent content published and in-press on the Coronavirus Disease 2019 (COVID-19) in the Journal of Thoracic Oncology, the official journal of the IASLC. 

JTO CRR Cover

JTO Clinical Research Reports COVID-19

Please find the most recent content published and in-press on the Coronavirus Disease 2019 (COVID-19) in JTO Clinical Research Reports the companion journal to the Journal of Thoracic Oncology

COVID-19 and Thoracic Malignancies

The COVID-19 and Cancer Consortium (CCC19) was formed on March 15, 2020, to study the clinical characteristics and course of illness among patients with COVID-19 who have a current or past history of cancer in order to better understand the vulnerability of these patients to COVID-19. 

COVID-19 in Thoracic Oncology Patients

COVID-19 AND CANCER

It is not easy to find a cohesive collection of relevant journal articles and rapidly changing guidelines about COVID-19 in relation to patients with cancer. Erin M. Bange, MD, is a first-year oncology fellow at Penn Medicine, a diverse clinical and research entity of the University of Pennsylvania. Dr. Bange has assembled oncology-specific information into a helpful document, which IASLC will be posting as updated every few days.

Supplemental Information
​​​​​​​Quick Reference 

Other Helpful Resources

Access various helpful resources:

  • General COVID-19 Q&A: Facts and Experiences
  • Guidelines/Recommendations from Other Medical Societies
  • Information from Government/Non-Government Organizations
  • Patient Resources
  • Peer-Reviewed Publications
  • Registries